Study of Human Orexin-1 and -2 G-Protein-Coupled Receptors with Novel and Published Antagonists by Modeling, Molecular Dynamics Simulations, and Site-Directed Mutagenesis
about
Physiology of the orexinergic/hypocretinergic system: a revisit in 2012OX1 and OX2 orexin/hypocretin receptor pharmacogeneticsStructure and ligand-binding mechanism of the human OX1 and OX2 orexin receptorsUsing the fragment molecular orbital method to investigate agonist-orexin-2 receptor interactionsBeyond Membrane Protein Structure: Drug Discovery, Dynamics and Difficulties.GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1-2 September 2014.Characterization of the dynamic events of GPCRs by automated computational simulations.Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA?Toward an understanding of agonist binding to human Orexin-1 and Orexin-2 receptors with G-protein-coupled receptor modeling and site-directed mutagenesis.Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies.Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics.Computational Methods Used in Hit-to-Lead and Lead Optimization Stages of Structure-Based Drug Discovery.The Human Orexin/Hypocretin Receptor Crystal Structures.Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold-Hopping Approach.GPCR Homology Model Generation for Lead Optimization.Mapping histamine H4receptor–ligand binding modes
P2860
Q26822470-36D3B5BB-D33D-4CE3-B0CF-FAD956DC6F46Q26865384-E639D583-0527-4718-B74C-4BC3465D1033Q27704228-37FE9197-0ED9-4169-A72C-A06C356A9430Q28818280-0FB26A6F-5C1E-4B4D-B526-38619D07B46EQ30392142-38BADCF2-BCBA-4027-96F9-1E0D8A94D2CFQ35830953-4DE908FB-D8B2-4EB8-A006-B5BD06A9738AQ38077229-3F164192-D87F-4021-BB2F-2ABAB5610748Q38221344-1F1E1D4F-8DA9-4337-8B16-EF420B9CE888Q41807597-18A45A6B-4630-4763-B4EC-E99F3186D180Q42088341-2B4B414F-D390-445F-B407-9A2460A21AF6Q44349574-66A11B89-B4C8-4B08-85A6-12814800744EQ47348631-701CD5FD-3BF2-415B-A4F2-C2DE401B640BQ47780061-1CC85EA7-3607-4BB2-B9A5-B1C0790ACE50Q47839193-82BDCE58-7ADD-4D2B-AD29-30067E51BE5BQ49501384-BB63D67C-7A23-4FCB-8896-72A5512F38EAQ56687985-730AB81B-AC4B-4765-9AE3-A017E0A0A560
P2860
Study of Human Orexin-1 and -2 G-Protein-Coupled Receptors with Novel and Published Antagonists by Modeling, Molecular Dynamics Simulations, and Site-Directed Mutagenesis
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Study of Human Orexin-1 and -2 ...... and Site-Directed Mutagenesis
@ast
Study of Human Orexin-1 and -2 ...... and Site-Directed Mutagenesis
@en
type
label
Study of Human Orexin-1 and -2 ...... and Site-Directed Mutagenesis
@ast
Study of Human Orexin-1 and -2 ...... and Site-Directed Mutagenesis
@en
prefLabel
Study of Human Orexin-1 and -2 ...... and Site-Directed Mutagenesis
@ast
Study of Human Orexin-1 and -2 ...... and Site-Directed Mutagenesis
@en
P2093
P3181
P356
P1433
P1476
Study of human Orexin-1 and -2 ...... and site-directed mutagenesis
@en
P2093
Alexander Heifetz
David Hallett
Dominique Manikowski
G Benjamin Morris
Jonathan Bentley
Mark Slack
Oliver Barker
Richard Law
Rita Reifegerste
Sandeep Pal
P304
P3181
P356
10.1021/BI300136H
P407
P577
2012-04-05T00:00:00Z